https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
rther tests or investigations in order to have a wider comprehension of patients' clinical situation and they are easily explainable when we have a physician's approach towards patient.OBJECTIVE To evaluate diffusion-weighted magnetic resonance imaging (DWI), 11C-choline positron emission tomography (PET), and fluorine-18-fluorodeoxyglucose (18F-FDG) PET for predicting Gleason score in prostate cancer patients. SUBJECTS AND METHODS The study cohort included 11 patients with biopsy-proven prostate cancer who underwent DWI, 11C-
Aimer
Commentaire
Partagez
